Document Archive Breakpoint tables for fungi QC tables Methodology Rationale documents Clinical breakpoints for fungi (v 11.0) - pdf file for printing (until 26 June, 2025) Clinical breakpoints for fungi (v 11.0) - excel file for screen (until 26 June, 2025) Clinical breakpoints for fungi (v 10.0) -…
Get to know moreMycobacteria (AMST) The EUCAST AMST develops breakpoints and methods for antimicrobial susceptibility testing of mycobacteria. Clinical breakpoints for Mycobacteria are part of the regular EUCAST breakpoint table for bacteria. For MIC distributions for Mycobacterium tuberculosis and other…
Get to know moreFungi (AFST) The EUCAST AFST develops breakpoints and methods for antimicrobial susceptibility testing of fungi. Clinical breakpoints for fungi are listed in a separate document and are not included into the breakpoint table for bacteria. For MIC distributions for fungi, go to the EUCAST MIC…
Get to know moreBreakpoints in brackets in EUCAST tables EUCAST breakpoints in brackets Guidance document, 1 December, 2021 Download PDF Recently, EUCAST introduced the concept of “breakpoints in brackets” to warn against the use of specific agents without the use of additional therapeutic measures. For these…
Get to know moreDevelopment of clinical breakpoints and ECOFFs As with other breakpoints for antimicrobials the background for EUCAST breakpoints are given in Rationale Documents. Since for antifungals specific technical issues in testing may exist, technical notes are developed if needed. As with the general…
Get to know moreRationale Documents Rationale documents pertaining to breakpoints determined by the EUCAST Veterinary Subcommittee. Florfenicol (Cattle) Rationale for EUCAST clinical breakpoints, version 1.0 10 August 2019 Download PDF Amoxicillin-Clavulanic Acid (AMC) Dog: oral and iv administration (VetCAST)…
Get to know moreGuidance Documents All Antibiotic Infection Methodology Pathogen Regulatory Document Title Date of Publication Previous Versions and Notes Infective endocarditis - EUCAST guidance on the reporting of antimicrobial susceptibility testing results July 2025 December 2024 Daptomycin in endocarditis and…
Get to know morePublic consultation Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated. Previous public consultations with comments and EUCAST responses 2025 Archive Proposed new breakpoints for…
Get to know moreWhen there are no antifungal breakpoints? 16 April 2024 first published on 16 April 2024, errata published 30 Sep, 2024: “dashes (“-“) are replaced by R, C. dubliniensis has been deleted as BPs have been set, and the species (dermatis) specified in table 2.” Download PDF EUCAST guidance on…
Get to know moreDevelopment of Clinical Breakpoints and ECOFFs The EUCAST AMST develops breakpoints and methods for antimicrobial susceptibility testing of mycobacteria. Rationale Documents Discover More Public Consultations A chance to review proposed EUCAST changes. Discover More Submit non-truncated MIC…
Get to know more
We’ve prepared a short video to help you get familiar with the new layout and features.